ClinicalTrials.Veeva

Menu

HD Sense Pilot Study - a Novel Method of Hemodynamic Monitoring

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Completed

Conditions

Hemodynamic Instability

Treatments

Device: ConCardiac

Study type

Observational

Funder types

Other

Identifiers

NCT03263988
HD Sense

Details and patient eligibility

About

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available.

Full description

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available. For this reason all patients will get a basic monitoring (NIBP, ECG, SpO2)

Enrollment

39 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elective surgery and general anesthesia
  • age >/= 18 years
  • any surgery in ENT/trauma/gynecology/visceral surgery/thoracic surgery/urology/neuro surgery/cardio surgery (N=10)
  • cardio surgery (N=10)
  • Transcatheter Aortic Valve Implantation (N=20)
  • cystectomy (N=10)
  • neurosurgery with an expected postoperative ICU stay >/= 20 hours (N=10)

Exclusion criteria

  • pregnant or breastfeeding patients
  • emergency surgery
  • participation in a clinical interventional study
  • BMI >35 kg/m²
  • impossibility to place the ConCardiac interlayer
  • difference of blood pressure of right and left arm > 12 mmHg
  • pAVK Fontaine IV
  • arrythmia absoluta
  • vitium cordis >/=3
  • ejection fraction <35%
  • TAPSE </=16mm
  • need of IABP

Trial design

39 participants in 1 patient group

PIEZO-Group
Description:
All patients in this study receive IBP by PICCO and piezocapacitative-interlayer-technology measurement.
Treatment:
Device: ConCardiac

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems